All stock lists
Anaptysbio, Inc (NASDAQ:ANAB)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
48.68-0.05 (-0.10%)
Insider Score
––Not scored
ANAB Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ANAB Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 27.49 M | 25.56 M | 108.25 M | 76.32 M | 22.26 M | 27.77 M |
| Revenue Growth (YoY) | 23.47 % | -7.98 % | 151.08 % | 154.26 % | 102.93 % | 286.84 % |
| Cost of Revenue | 2.70 M | 610.00 K | -107.99 M | 31.41 M | 37.82 M | 41.18 M |
| Gross Profit | 30.19 M | 24.95 M | 216.24 M | 44.91 M | -15.56 M | -13.41 M |
| SG&A Expense | 16.04 M | 26.20 M | 15.79 M | 10.21 M | 10.61 M | 14.13 M |
| R&D Expense | 2.70 M | 33.86 M | 25.56 M | 31.41 M | 37.82 M | 41.18 M |
| Operating Expenses | 10.64 M | 59.58 M | 149.34 M | 10.21 M | 10.61 M | 14.13 M |
| Operating Income | 66.96 M | -34.64 M | 66.90 M | 34.70 M | -26.17 M | -27.54 M |
| Pretax Income | 47.75 M | -52.84 M | 49.70 M | 15.11 M | -38.59 M | -39.28 M |
| Tax Provision | -181.49 M | 40.00 K | 81.00 K | 0.00 | 39.00 K | 44.00 K |
| Net Income | 183.88 M | -52.88 M | 49.61 M | 15.11 M | -38.63 M | -39.33 M |
| EPS (Basic) | 6.28 | -1.84 | 1.79 | 0.52 | -1.34 | -1.28 |
| EPS (Diluted) | 5.11 | -1.84 | 1.58 | 0.52 | -1.34 | -1.28 |
| Shares Outstanding | 29.26 M | 28.69 M | 27.79 M | 29.02 M | 28.81 M | 30.64 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.